Martin L Miller

Martin L Miller

University of Cambridge

H-index: 30

Europe-United Kingdom

About Martin L Miller

Martin L Miller, With an exceptional h-index of 30 and a recent h-index of 26 (since 2020), a distinguished researcher at University of Cambridge, specializes in the field of Immunogenomics, Systems Biology, Proteomics, Tumor Microenvironment.

His recent articles reflect a diverse array of research interests and contributions to the field:

Multimodal real world data reveals immunogenomic drivers of acquired and primary resistance to immune checkpoint blockade

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

Treatment and prognosis of pancreatic cancer

620 Multimodal real world data reveals immunogenomic drivers of acquired and primary resistance to immune checkpoint blockade

Cell-of-origin–specific proteomics of extracellular vesicles

522 Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

BIM-basierte Digitalisierung von Bestandsgebäuden aus Sicht des FM am Beispiel von Heizungsanlagen

Promises and challenges of adoptive T-cell therapies for solid tumours

Martin L Miller Information

University

Position

Cancer Research UK Cambridge Institute

Citations(all)

24078

Citations(since 2020)

14868

Cited By

16099

hIndex(all)

30

hIndex(since 2020)

26

i10Index(all)

38

i10Index(since 2020)

32

Email

University Profile Page

University of Cambridge

Google Scholar

View Google Scholar Profile

Martin L Miller Skills & Research Interests

Immunogenomics

Systems Biology

Proteomics

Tumor Microenvironment

Top articles of Martin L Miller

Title

Journal

Author(s)

Publication Date

Multimodal real world data reveals immunogenomic drivers of acquired and primary resistance to immune checkpoint blockade

Cancer Research

Mohamed Reda Keddar

Sebastian Carrasco Pro

Kathleen Burke

Ana Camelo Stewart

Mark Cobbold

...

2024/3/22

Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

Cancer Cell

Danish Memon

Adam J Schoenfeld

Darwin Ye

George Fromm

Hira Rizvi

...

2024/2/12

Treatment and prognosis of pancreatic cancer

2023/3/2

620 Multimodal real world data reveals immunogenomic drivers of acquired and primary resistance to immune checkpoint blockade

Mohamed Reda Keddar

Sebastian Carrasco Pro

Kathleen Burke

Roy Rabbie

Ana Stewart

...

2023/11/1

Cell-of-origin–specific proteomics of extracellular vesicles

PNAS Nexus

Sebastian Kehrloesser

Oliver Cast

Thomas S Elliott

Russell J Ernst

Anne C Machel

...

2023/4

522 Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

Danish Memon

Matthew Hellmann

Martin Miller

2022/11/1

BIM-basierte Digitalisierung von Bestandsgebäuden aus Sicht des FM am Beispiel von Heizungsanlagen

Martin Miller

2022

Promises and challenges of adoptive T-cell therapies for solid tumours

Matteo Morotti

Ashwag Albukhari

Abdulkhaliq Alsaadi

Mara Artibani

James D Brenton

...

2021/5/25

Copy number aberrations drive kinase rewiring, leading to genetic vulnerabilities in cancer

Cell reports

Danish Memon

Michael B Gill

Evangelia K Papachristou

David Ochoa

Clive S D’Santos

...

2021/5/18

The development of an in vivo model of checkpoint acquired resistance, reveals a program of interferon hyperstimulation, resulting in dysregulation of MHC class I, protein …

Cancer Research

George J Fromm

Danish Memon

Suresh de Silva

Kyung Jin Yoo

Kellsey Johannes

...

2021/7/1

Ovarian tumors orchestrate distinct cellular compositions

Immunity

Berna Bou-Tayeh

Martin L Miller

2021/6/8

Unraveling tumor–immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy

Nature Genetics

Alejandro Jiménez-Sánchez

Paulina Cybulska

Katherine LaVigne Mager

Simon Koplev

Oliver Cast

...

2020/6

Acquired resistance to PD-1 blockade in NSCLC.

Adam Jacob Schoenfeld

Hira Rizvi

Danish Memon

Jia Luo

Isabel Ruth Preeshagul

...

2020/5/20

Integrated multi-tumor radio-genomic marker of outcomes in patients with high serous ovarian carcinoma

Cancers

Harini Veeraraghavan

Herbert Alberto Vargas

Alejandro Jimenez-Sanchez

Maura Micco

Eralda Mema

...

2020/11/17

Abstract IA07: UVB-induced tumor heterogeneity directs immune response in melanoma

Cancer Research

Osnat Bartok

Sushant Patkar

Sapir Cohen

Kevin Litchfield

Hiren Karathia

...

2020/11/1

Multi-site clonality analysis uncovers pervasive heterogeneity across melanoma metastases

Nature communications

Roy Rabbie

Naser Ansari-Pour

Oliver Cast

Doreen Lau

Francis Scott

...

2020/8/27

See List of Professors in Martin L Miller University(University of Cambridge)

Co-Authors

H-index: 121
Søren Brunak

Søren Brunak

Københavns Universitet

H-index: 100
Lars Juhl Jensen

Lars Juhl Jensen

Københavns Universitet

H-index: 89
Naiyer A. Rizvi

Naiyer A. Rizvi

Columbia University in the City of New York

H-index: 85
Gianni Cesareni

Gianni Cesareni

Università degli Studi di Roma Tor Vergata

H-index: 52
Vladimir Makarov

Vladimir Makarov

National Research University Higher School of Economics

H-index: 28
Nikolaj Sorgenfrei Blom

Nikolaj Sorgenfrei Blom

Danmarks Tekniske Universitet

academic-engine